Table 1.
Allele | OR (95% CI) | p Value | ||
---|---|---|---|---|
T (%) | C (%) | |||
rs1126579 | ||||
Control | 316 (65.0) | 170 (35.0) | ||
PE | 265 (55.7) | 211 (44.3) | 1.48 (1.14–1.92) | 0.03 |
PE | ||||
SPE | 212 (53.8) | 182 (46.2) | 1.60 (1.22–2.10) | 0.001 |
MPE | 53 (64.6) | 29 (35.4) | 1.02 (0.62–1.66) | 0.95 |
SPE | ||||
Early‐onset | 88 (53.0) | 78 (47.0) | 1.65 (1.15–2.36) | 0.006 |
Late‐onset | 124 (54.4) | 104 (45.6) | 1.56 (1.32–2.15) | 0.006 |
rs2230054 | ||||
Control | 134 (28) | 352 (72) | ||
PE | 147 (31) | 329 (69) | 1.17 (0.84–1.55) | 0.26 |
PE | ||||
SPE | 122 (31.0) | 272 (69.0) | 1.18 (0.88–1.58) | 0.27 |
MPE | 25 (30.5) | 57 (69.5) | 1.15 (0.69–1.92) | 0.58 |
SPE | ||||
Early‐onset | 51 (30.7) | 115 (69.3) | 1.17 (0.79–1.71) | 0.44 |
Late‐onset | 71 (31.1) | 157 (68.9) | 1.19 (0.84–1.68) | 0.33 |
Bold faced values indicate a significant difference at the 5% level.
PE: preeclampsia; MPE: mild preeclampsia; SPE: severe preeclampsia.